Ariadne and Aureus Pharma to Collaborate for Support of Knowledge Management Solutions
News May 26, 2010
Ariadne and Aureus are joining forces with the goal to deliver knowledge management solutions for the life sciences industry, and announce that Ariadne will distribute Aureus’ offerings in the US.
The two companies will initiate a collaboration to explore together further synergies between their respective knowledge management solutions and more particularly the interfaces between the protein pathway space and medicinal chemistry. Such interfaces will help customers to better understand mechanisms of actions between therapeutic proteins, protein pathways and small molecules and provide new insights in the disease biology area.
“This engagement highlights the ongoing evolution of Ariadne,” says Ilya Mazo, Ph.D. and CEO, “by partnering with best-in-class providers of knowledge management solutions. We can provide solutions that enable customers to take advantage of both Ariadne and Aureus’ products where it makes sense in their organization, workflow and informatics infrastructure. We believe that this collaboration will make it possible to offer the highest level of interoperability between our companies, along with improved solutions for knowledge management.”
“The partnership between Aureus and Ariadne will enable to support synergies in discovery and development workflows as used across multiple departments and scientific disciplines in the Life Science Industry,” says Jason Theodosiou, CEO of Aureus Pharma. “Both companies are innovative and have created solutions that organize high quality data from various sources to better identify, create, distribute, and enable knowledge integration within an organization.”
The collaboration will establish confidence between researchers in disease biology and medicinal chemistry that the technologies they use and deploy in their specific environments provide continuity in the pipeline discovery process, align common goals in knowledge management and increase scientific comprehension between these two groups.
Financial terms were not disclosed.
New Speakers from Roche and Imperial College London Announced for SMi’s ADMET EventNews
SMi Group Reports: With less than 4 weeks left until the 13th annual ADMET Conference commences in London, SMi announces two new speakers joining the event.READ MORE
Compound as Effective as FDA-Approved Drugs Against Life-Threatening InfectionsNews
Purdue University researchers have identified a new compound that in preliminary testing has shown itself to be as effective as antibiotics approved by the Food and Drug Administration to treat life-threatening infections while also appearing to be less susceptible to bacterial resistance.READ MORE